Literature DB >> 22325359

Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.

Anne Goriely1, Andrew O M Wilkie.   

Abstract

Advanced paternal age has been associated with an increased risk for spontaneous congenital disorders and common complex diseases (such as some cancers, schizophrenia, and autism), but the mechanisms that mediate this effect have been poorly understood. A small group of disorders, including Apert syndrome (caused by FGFR2 mutations), achondroplasia, and thanatophoric dysplasia (FGFR3), and Costello syndrome (HRAS), which we collectively term "paternal age effect" (PAE) disorders, provides a good model to study the biological and molecular basis of this phenomenon. Recent evidence from direct quantification of PAE mutations in sperm and testes suggests that the common factor in the paternal age effect lies in the dysregulation of spermatogonial cell behavior, an effect mediated molecularly through the growth factor receptor-RAS signal transduction pathway. The data show that PAE mutations, although arising rarely, are positively selected and expand clonally in normal testes through a process akin to oncogenesis. This clonal expansion, which is likely to take place in the testes of all men, leads to the relative enrichment of mutant sperm over time-explaining the observed paternal age effect associated with these disorders-and in rare cases to the formation of testicular tumors. As regulation of RAS and other mediators of cellular proliferation and survival is important in many different biological contexts, for example during tumorigenesis, organ homeostasis and neurogenesis, the consequences of selfish mutations that hijack this process within the testis are likely to extend far beyond congenital skeletal disorders to include complex diseases, such as neurocognitive disorders and cancer predisposition.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22325359      PMCID: PMC3276674          DOI: 10.1016/j.ajhg.2011.12.017

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  196 in total

1.  New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma.

Authors:  L S Chitty; D R Griffin; C Meaney; A Barrett; A Khalil; E Pajkrt; T J Cole
Journal:  Ultrasound Obstet Gynecol       Date:  2011-02-01       Impact factor: 7.299

2.  Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability.

Authors:  Feng Zhang; Pavel Seeman; Pengfei Liu; Marian A J Weterman; Claudia Gonzaga-Jauregui; Charles F Towne; Sat Dev Batish; Els De Vriendt; Peter De Jonghe; Bernd Rautenstrauss; Klaus-Henning Krause; Mehrdad Khajavi; Jan Posadka; Antoon Vandenberghe; Francesc Palau; Lionel Van Maldergem; Frank Baas; Vincent Timmerman; James R Lupski
Journal:  Am J Hum Genet       Date:  2010-05-20       Impact factor: 11.025

Review 3.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.

Authors:  Z Vajo; C A Francomano; D J Wilkin
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

4.  Parental age and risk of schizophrenia: a case-control study.

Authors:  Majella Byrne; Esben Agerbo; Henrik Ewald; William W Eaton; Preben Bo Mortensen
Journal:  Arch Gen Psychiatry       Date:  2003-07

5.  The birth prevalence rates for the skeletal dysplasias.

Authors:  I M Orioli; E E Castilla; J G Barbosa-Neto
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

Review 6.  Spermatocytic seminoma.

Authors:  J N Eble
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

7.  Paternal age and adverse birth outcomes: teenager or 40+, who is at risk?

Authors:  Xi-Kuan Chen; Shi Wu Wen; Daniel Krewski; Nathalie Fleming; Qiuying Yang; Mark C Walker
Journal:  Hum Reprod       Date:  2008-02-06       Impact factor: 6.918

8.  Exome sequencing supports a de novo mutational paradigm for schizophrenia.

Authors:  Bin Xu; J Louw Roos; Phillip Dexheimer; Braden Boone; Brooks Plummer; Shawn Levy; Joseph A Gogos; Maria Karayiorgou
Journal:  Nat Genet       Date:  2011-08-07       Impact factor: 38.330

9.  The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects.

Authors:  Sara Ota; Zi-Qiang Zhou; Jason M Link; Peter J Hurlin
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

10.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

View more
  111 in total

1.  Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia.

Authors:  Kathrein von Kopylow; Hannah Staege; Wolfgang Schulze; Hans Will; Christiane Kirchhoff
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

2.  Treatment timing and multidisciplinary approach in Apert syndrome.

Authors:  Maria Teresa Fadda; Gaetano Ierardo; Barbara Ladniak; Gianni Di Giorgio; Alessandro Caporlingua; Ingrid Raponi; Alessandro Silvestri
Journal:  Ann Stomatol (Roma)       Date:  2015-07-28

3.  Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function.

Authors:  April N Meyer; Peggy Modaff; Clark G Wang; Elizabeth Wohler; Nara L Sobreira; Daniel J Donoghue; Richard M Pauli
Journal:  Am J Med Genet A       Date:  2020-12-02       Impact factor: 2.802

4.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

Review 5.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

Review 6.  DNA damage in aging, the stem cell perspective.

Authors:  Taylor McNeely; Michael Leone; Hagai Yanai; Isabel Beerman
Journal:  Hum Genet       Date:  2019-07-19       Impact factor: 4.132

7.  The Age of the Father.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-04-20

8.  Genetics: The rate of human mutation.

Authors:  Alexey Kondrashov
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

Review 9.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

Review 10.  Ageing of the male germ line.

Authors:  Catriona Paul; Bernard Robaire
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.